Sinopharm Group Announces Leadership Changes

Sinopharm Group Co ( (HK:1099) ) has issued an announcement.

Sinopharm Group Co. Ltd. announced the resignation of Mr. Hu Ligang from his position as a non-executive director, effective immediately, with his subsequent appointment as vice president of the company. The board expressed gratitude for Mr. Hu’s contributions to the company’s strategic development. Simultaneously, the board proposed the appointment of Mr. Ma Yue as a non-executive director, pending shareholder approval. Mr. Ma, a senior economist and practicing pharmacist, brings extensive experience from his tenure at China National Pharmaceutical Group Co., Ltd.

The most recent analyst rating on (HK:1099) stock is a Buy with a HK$29.30 price target. To see the full list of analyst forecasts on Sinopharm Group Co stock, see the HK:1099 Stock Forecast page.

More about Sinopharm Group Co

Sinopharm Group Co. Ltd. is a prominent company in the pharmaceutical industry, focusing on the distribution and retail of pharmaceutical and healthcare products. It is registered as a non-Hong Kong company under the Hong Kong Companies Ordinance.

YTD Price Performance: -12.30%

Average Trading Volume: 7,885,508

Technical Sentiment Signal: Sell

Current Market Cap: HK$58.26B

Find detailed analytics on 1099 stock on TipRanks’ Stock Analysis page.